Platelet factor 3 (PF3) and primary hemostasis: ditazol test
Di Micco, B.; Boeri, F.; Pagliara, E.; Cinque, M.R.; Messina, M.F.; Marcacci, M.
La Pediatria 87(2): 237-243
1979
ISSN/ISBN: 0031-3890 PMID: 44904 Document Number: 141957
Document emailed within 1 workday
Related Documents
Famulari, C.; Perri, S.; Terranova, M.L.; Versaci, A.; Cuzzocrea, D.; Barberi, I. 1982: Behavior of platelet aggregation in the postoperative period after ditazol treatment La Clinica Terapeutica 103(6): 601-621Brassard, J.A.; Meyers, K.M. 1991: Evaluation of the buccal bleeding time and platelet glass bead retention as assays of hemostasis in the dog: the effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency Thrombosis and Haemostasis 65(2): 191-195
Seguchi, M.; Nakajima, S. 1995: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4 Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 74(3): 255-257
Hirschman, R.J.; Gralnick, H.R. 1974: A simplified platelet factor 3 (PF-3) assay for the rapid detection of platelet isoantibodies and an antiplatelet factor in ATP and SLE Journal of Laboratory and Clinical Medicine 84(2): 292-297
Hwang, S.B.; Li, C.L.; Lam, M.H.; Shen, T.Y. 1985: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist Laboratory Investigation; a Journal of Technical Methods and Pathology 52(6): 617-630
Issekutz, A.C.; Szpejda, M. 1986: Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988 Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 275-281
Floch, A.; Tahraoui, L.; Sedivy, P.; Cavero, I. 1991: The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes Journal of Pharmacology and Experimental Therapeutics 258(2): 567-575
Andresen, J.L.; Ehlers, N. 1998: Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta Current Eye Research 17(1): 79-87
Charnaia, M.A.; Morozov, I.A.; Gladysheva, V.G.; Belov, I.V.; Isaeva, A.M. 2005: The platelet componentof hemostasis in aortic surgery Angiologiia i Sosudistaia Khirurgiia 11(3): 7-12
Walsh, P.N. 1985: Platelet-mediated coagulant protein interactions in hemostasis Seminars in Hematology 22(3): 178-186
Holt, J.C.; Niewiarowski, S. 1989: Platelet basic protein, low-affinity platelet factor 4, and beta-thromboglobulin: purification and identification Methods in Enzymology 169: 224-233
Macpherson, J.L.; Kemp, A.; Rogers, M.; Mallet, A.I.; Toia, R.F.; Spur, B.; Earl, J.W.; Chesterman, C.N.; Krilis, S.A. 1989: Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis Clinical and Experimental Immunology 77(3): 391-396
Chekalina, S.I.; Umurzakova, R.Z.; Saliev, K.K.; Abdurakhmanov, T.R. 1994: Effect of berberine bisulfate on platelet hemostasis in thrombocytopenia patients Gematologiia i Transfuziologiia 39(5): 33-35
Antiuf'ev, V.F.; Sukhanov, V.A. 1983: Action of obsidan on platelet hemostasis in patients with atrial fibrillation Klinicheskaia Meditsina 61(10): 64-67
Rizzino, A.; Kazakoff, P.; Ruff, E.; Kuszynski, C.; Nebelsick, J. 1988: Regulatory effects of cell density on the binding of transforming growth factor beta, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor Cancer Research 48(15): 4266-4271
Reed, G.L.; Matsueda, G.R.; Haber, E.; Haber, E. 1992: Platelet factor XIIi increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin Thrombosis and Haemostasis 68(3): 315-320
Pfueller, S.L.; Howard, M.A.; White, J.G.; Menon, C.; Berry, E.W. 1987: Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome Thrombosis and Haemostasis 58(4): 1060-1063
Ishioka, S.; Saito, T.; Hiyama, K.; Haruta, Y.; Maeda, A.; Hozawa, S.; Inamizu, T.; Yamakido, M. 1996: Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 13(2): 139-145
Moake, J.L.; Cimo, P.L.; Widmer, K.; Peterson, D.M.; Gum, J.R. 1977: Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems Thrombosis and Haemostasis 38(2): 420-428
Zadionchenko, V.S.; Kamenker, E.S.; Chikvashvili, I.A. 1989: Changes in the platelet-vascular system of hemostasis in patients with ischemic heart disease and hypertension after the treatment Kardiologiia 29(10): 51-54